Automated surveillance of non-ventilator-associated hospital-acquired pneumonia (nvHAP): a systematic literature review.

Autor: Wolfensberger A; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. aline.wolfensberger@usz.ch.; Institute for Implementation Science in Healthcare, University of Zurich, Zurich, Switzerland. aline.wolfensberger@usz.ch., Scherrer AU; Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland., Sax H; Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.

Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Mar 06; Vol. 13 (1), pp. 30. Date of Electronic Publication: 2024 Mar 06.

Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.

Autor: Jakeman B; Department of Pharmaceutical Practice and Administrative Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.; Department of Medicine, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Scherrer AU; Departments of Medicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Darling KEA; Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Damas J; Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Bieler-Aeschlimann M; Service of Neurology, Department of Neurosciences, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland., Hasse B; Departments of Medicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Schlosser L; Department of Neuropsychology, Neurology Clinic, University Hospital Zurich, Zurich, Switzerland., Hachfeld A; Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland., Gutbrod K; Department of Neurology, University Hospital Bern, University of Bern, Neurozentrum Bern, Switzerland., Tarr PE; University Department of Medicine, Kantonsspital Bruderholz, University of Basel, Basel, Switzerland., Calmy A; Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Assal F; Service of Neurology, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Kunze U; Memory Clinic, Felix Platter Hospital University Center for Medicine of Aging, Basel, Switzerland., Stoeckle M; Department of Medicine, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Schmid P; Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Toller G; Neuropsychology Unit, Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Rossi S; Neuropsychology and Speech Therapy Unit, Neurocenter of Southern Switzerland, Regional Hospital Lugano, Lugano, Switzerland., di Benedetto C; Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland., du Pasquier R; Service of Neurology, Department of Neurosciences, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland., Cavassini M; Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Marzolini C; Department of Medicine, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2022 Sep 02; Vol. 9 (9), pp. ofac457. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).

Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).

Autor: Scherrer AU; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Traytel A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Braun DL; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Calmy A; Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Battegay M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Cavassini M; Division of Infectious Diseases, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland., Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Schmid P; Division of Infectious Diseases, Cantonal Hospital St Gallen, St Gallen, Switzerland., Bernasconi E; Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland., Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Kahlert C; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland., Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Kouyos RD; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Tarr P; University Department of Medicine, Kantonsspital Bruderholz, University of Basel, Bruderholz, Switzerland., Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Fellay J; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Bucher H; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Yerly S; Division of Infectious Diseases and Laboratory of Virology, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Suter F; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Hirsch H; Department of Biomedicine, University of Basel, Basel, Switzerland., Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Dollenmaier G; Zentrum für Labormedizin, St Gallen, Switzerland., Perreau M; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland., Martinetti G; Department of Microbiology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Rauch A; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Publikováno v: International journal of epidemiology [Int J Epidemiol] 2022 Feb 18; Vol. 51 (1), pp. 33-34j.

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment.

Autor: Pyngottu A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Scherrer AU; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Kouyos R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Hirsch H; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Perreau M; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; University of Lausanne, Lausanne, Switzerland., Yerly S; Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva, Switzerland., Calmy A; Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva, Switzerland., Cavassini M; Division of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland., Stöckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland., Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Vernazza P; Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Bernasconi E; Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland., Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2134-e2141.

The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.

Autor: Glass TR; Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Calmy A; Division of Infectious Diseases, University Hospital Geneva, Geneva, Switzerland., Bernasconi E; Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland., Scherrer AU; Swiss HIV Cohort Data Center, Zurich, Switzerland., Battegay M; University of Basel, Basel, Switzerland.; Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland., Steffen A; Division of Infectious Diseases, Kantonsspital St Gallen, St Gallen, Switzerland., Böni J; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Yerly S; Laboratory of Virology, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Klimkait T; Department of Biomedicine, University of Basel, Basel, Switzerland., Cavassini M; Division of Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland., Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Apr 26; Vol. 72 (8), pp. 1413-1421.